[Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis]. 1981

V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1990, Voprosy pitaniia,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1980, Voprosy revmatizma,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1988, Sovetskaia meditsina,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1981, Terapevticheskii arkhiv,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1980, Terapevticheskii arkhiv,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1983, Revmatologiia (Moscow, Russia),
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
October 1990, Annals of the rheumatic diseases,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1992, Terapevticheskii arkhiv,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 2010, Terapevticheskii arkhiv,
V G Tsitlanadze, and L M Dzidziguri, and L M Tkemaladze, and E Iu Kartvelishvili, and N A Shakulashvili
January 1984, Revmatologiia (Moscow, Russia),
Copied contents to your clipboard!